Bank Julius Baer & Co. Ltd, Zurich Dyadic International Inc Transaction History

Bank Julius Baer & Co. Ltd, Zurich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.3 - $6.49 $8,273 - $16,270	-2,507 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$3.35 - $5.67 $23 - $39	7 Added 0.28%	2,507 $9,000
Q1 2021 May 10, 2021	BUY	$4.75 - $6.87 $2,161 - $3,125	455 Added 22.25%	2,500 $14,000
Q4 2020 Feb 24, 2021	BUY	$5.35 - $7.77 $10,812 - $15,703	2,021 Added 8420.83%	2,045 $11,000
Q4 2020 Feb 12, 2021	SELL	$5.35 - $7.77 $10,571 - $15,353	-1,976 Reduced 98.8%	24 $11,000
Q3 2020 Nov 10, 2020	BUY	$7.22 - $9.11 $14,440 - $18,220	2,000 New	2,000 $15,000

5.12M

27.1K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $43.8M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.